Skip to content

Viridian Therapeutics, Inc. VRDN Segment Reporting Other Item Amount

Segment Reporting Other Item Amount at other companies

Century Communities logo
Century CommunitiesCCS
$22.22M+279%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$4.06M+16.7%
Equitable Holdings logo
Equitable HoldingsEQH
$371M-5.1%
Essential Utilities logo
Essential UtilitiesWTRG
-$75K+74.4%
Proto Labs logo
Proto LabsPRLB
$128.08M+5.2%
ICF International logo
ICF InternationalICFI
$660K-31.7%

Segments

By segment

See full
Reportable Segment-$11.29M-63.4%

Other financials

Income statement

See full
Revenue$141.0K+95.8%
Operating income-$116.2M-23.8%
Net income-$104.9M-20.7%
EPS (diluted)-$1.15-5.5%

Balance sheet

See full
Cash & equivalents$176.3M+51.7%
Total debt$36.8M+59.4%
Total equity$636.0M+5.2%
Total assets$789.0M+19.4%

Cash flow

See full
Operating cash flow-$119.7M-29.1%
CapEx$23.0K-73.3%
Free cash flow-$119.7M-29.0%

Valuation

See full
Market cap$1.91B+82.0%

Profitability

See full
Gross margin36.3%
Operating margin-543.9%-271pp
Net margin-508.5%-254pp
FCF margin-428.4%-214pp

Returns & leverage

See full
Return on equity-58.1%+7.9pp
Debt / equity0.1×0.0×
Current ratio15.1×-4.3×